Global Bisoprolol Fumarate Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Bisoprolol Fumarate Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Bisoprolol Fumarate is the fumarate salt of a synthetic phenoxy-2-propanol-derived cardioselective beta-1 adrenergic receptor antagonist with antihypertensive and potential cardioprotective activities. Devoid of intrinsic sympathomimetic activity, bisoprolol selectively and competitively binds to and blocks beta-1 adrenergic receptors in the heart, decreasing cardiac contractility and rate, reducing cardiac output, and lowering blood pressure. In addition, this agent may exhibit antihypertensive activity through the inhibition of renin secretion by juxtaglomerular epithelioid (JGE) cells in the kidney, thus inhibiting activation of the renin-angiotensin system (RAS). Bisoprolol has been shown to be cardioprotective in animal models.
Bisoprolol Fumarate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bisoprolol Fumarate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Bisoprolol Fumarate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Bisoprolol Fumarate key manufacturers include Merck & Co Inc, Intaspharma, Taj Pharma, Jincheng Taier, Yangtze River Pharmaceutical (Group) Co., Ltd., Jiangsu Simcere Pharmaceutical Co., Ltd., Chengdu Easton Biopharmaceuticals Co., Ltd., The Yueyang Xinhua Pharmaceutical Co., Ltd. and Wellso Pharmaceutical, etc. Merck & Co Inc, Intaspharma, Taj Pharma are top 3 players and held % sales share in total in 2022.
Bisoprolol Fumarate can be divided into Bisoprolol Fumarate Tablets and Bisoprolol Fumarate Capsules, etc. Bisoprolol Fumarate Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Bisoprolol Fumarate is widely used in various fields, such as Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others, etc. Hospital Pharmacy provides greatest supports to the Bisoprolol Fumarate industry development. In 2022, global % sales of Bisoprolol Fumarate went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bisoprolol Fumarate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck & Co Inc
Intaspharma
Taj Pharma
Jincheng Taier
Yangtze River Pharmaceutical (Group) Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Chengdu Easton Biopharmaceuticals Co., Ltd.
The Yueyang Xinhua Pharmaceutical Co., Ltd.
Wellso Pharmaceutical
Segment by Type
Bisoprolol Fumarate Tablets
Bisoprolol Fumarate Capsules
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Bisoprolol Fumarate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Bisoprolol Fumarate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Bisoprolol Fumarate industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Bisoprolol Fumarate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Bisoprolol Fumarate introduction, etc. Bisoprolol Fumarate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Bisoprolol Fumarate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Bisoprolol Fumarate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bisoprolol Fumarate market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Bisoprolol Fumarate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Bisoprolol Fumarate key manufacturers include Merck & Co Inc, Intaspharma, Taj Pharma, Jincheng Taier, Yangtze River Pharmaceutical (Group) Co., Ltd., Jiangsu Simcere Pharmaceutical Co., Ltd., Chengdu Easton Biopharmaceuticals Co., Ltd., The Yueyang Xinhua Pharmaceutical Co., Ltd. and Wellso Pharmaceutical, etc. Merck & Co Inc, Intaspharma, Taj Pharma are top 3 players and held % sales share in total in 2022.
Bisoprolol Fumarate can be divided into Bisoprolol Fumarate Tablets and Bisoprolol Fumarate Capsules, etc. Bisoprolol Fumarate Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Bisoprolol Fumarate is widely used in various fields, such as Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others, etc. Hospital Pharmacy provides greatest supports to the Bisoprolol Fumarate industry development. In 2022, global % sales of Bisoprolol Fumarate went into Hospital Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bisoprolol Fumarate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck & Co Inc
Intaspharma
Taj Pharma
Jincheng Taier
Yangtze River Pharmaceutical (Group) Co., Ltd.
Jiangsu Simcere Pharmaceutical Co., Ltd.
Chengdu Easton Biopharmaceuticals Co., Ltd.
The Yueyang Xinhua Pharmaceutical Co., Ltd.
Wellso Pharmaceutical
Segment by Type
Bisoprolol Fumarate Tablets
Bisoprolol Fumarate Capsules
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Bisoprolol Fumarate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Bisoprolol Fumarate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Bisoprolol Fumarate industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Bisoprolol Fumarate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Bisoprolol Fumarate introduction, etc. Bisoprolol Fumarate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Bisoprolol Fumarate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices